Bioregenx (BRGX) Non-Current Debt (2021 - 2026)

Bioregenx's Non-Current Debt history runs 6 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Non-Current Debt rose 341.33% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 341.33% increase from a year earlier, with the FY2025 full-year figure at $168304.0, down 85.22% from the prior year.
• Non-Current Debt rose to $1.1 million in Q1 2026 per BRGX's latest filing, from $168304.0 in the prior quarter.
• Across five years, Non-Current Debt topped out at $1.2 million in Q3 2024 and bottomed at $168304.0 in Q4 2025.
• The 5-year median for Non-Current Debt is $249599.0 (2024), against an average of $504023.9.
• Across the five-year window, Non-Current Debt soared 381.61% in 2024 and tumbled 85.22% in 2025, its largest moves.
• Year by year, Non-Current Debt stood at $200000.0 in 2022, then jumped by 162.84% to $525681.0 in 2023, then soared by 116.62% to $1.1 million in 2024, then tumbled by 85.22% to $168304.0 in 2025, then jumped by 574.48% to $1.1 million in 2026.
• Per Business Quant, the three latest BRGX Non-Current Debt figures stand at $1.1 million (Q1 2026), $168304.0 (Q4 2025), and $181069.0 (Q3 2025).